China Sleep-Wake Disorder Market
China Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)
Industry Overview
China sleep-wake disorder market was valued at $1.8 billion in 2025 and is projected to reach $3.4 billion by 2035, growing at a CAGR of 6.4% from 2026 to 2035. The market in China is experiencing steady expansion driven by increasing demand across multiple end-use sectors. Continuous improvements in industrial capabilities and infrastructure development are further supporting this upward trajectory. Rising investments in technology adoption and modernization initiatives are strengthening market performance. In addition, favorable government policies and supportive regulatory frameworks are contributing to sustained growth momentum. Expanding consumer awareness and evolving preferences are also playing a significant role in shaping demand patterns. Overall, the market is expected to maintain a positive growth outlook in the coming years.
Market Dynamics
Technological Advancement and Digital Integration
The China market is undergoing a significant transformation driven by continuous technological progress and digital adoption across industries. The increasing deployment of advanced technologies is enhancing efficiency and operational performance. Organizations are incorporating automation and data-driven systems to improve accuracy and productivity. Expansion of smart infrastructure and connected solutions is enabling better resource utilization. Growing emphasis on innovation is encouraging companies to upgrade existing processes. This ongoing digital shift is strengthening the overall competitiveness of the market.
Expanding Domestic Demand and Policy Support
The China market is experiencing robust growth supported by rising domestic demand and favorable policy measures. Increasing urbanization and improved living standards are driving higher consumption levels across various sectors. Government initiatives aimed at industrial development are further supporting market expansion. Investments in manufacturing and service capabilities are enhancing supply chain strength. Businesses are benefiting from improved market access and expanding customer bases. These combined factors are fostering a stable and sustained growth environment.
Market Segmentation
- Based on the disorder type, the market is segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm sleep-wake disorders, parasomnias, dyssomnias, and others.
- Based on the treatment type, the market is segmented into pharmacological therapy, behavioral therapy, light therapy, device-based therapy, and others.
- Based on the diagnosis & management approach, the market is segmented into polysomnography & sleep studies, actigraphy-based monitoring, clinical evaluation & screening tools, and remote/digital sleep monitoring solutions.
- Based on the application, the market is segmented into hospitals, home care settings, and others.
Sleep Apnea Segment to Lead the Market with the Largest Share
The sleep apnea segment is witnessing notable growth due to the increasing prevalence of breathing-related sleep disorders. Rising awareness regarding early diagnosis and long-term health risks is driving higher patient screening rates. Technological advancements in diagnostic sleep studies are improving detection accuracy and treatment outcomes. Key players such as ResMed Inc. and Inspire Medical Systems Inc. are strengthening their presence through innovative therapeutic solutions. The growing preference for home-based sleep testing and monitoring solutions is further supporting market expansion. Continuous product innovation and expanding healthcare accessibility are expected to sustain segment momentum.
Device-Based Therapy: A Key Segment in Market Growth
Device-based therapy is emerging as a rapidly advancing segment driven by increasing adoption of non-pharmacological treatment options. Continuous positive airway pressure (CPAP) devices and advanced airway stimulation systems are gaining strong traction among patients. Companies such as ResMed Inc. are focusing on improving device comfort, portability, and digital connectivity features. Rising demand for home-use therapeutic devices is encouraging innovation in compact and user-friendly designs. Integration of smart monitoring and cloud-based data tracking is enhancing treatment adherence and clinical outcomes. The segment is expected to grow steadily with increasing preference for personalized sleep disorder management solutions.
Market Players Outlook
The major companies operating in the China sleep-wake disorder market include Shanghai Fosun Pharmaceutical Group Co. Ltd., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Shanghai Pharmaceuticals Holding Co. Ltd., Sinopharm Group Co. Ltd., and BeiGene Ltd., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In June 2025, Simcere Pharmaceutical Group initiated the launch of QUVIVIQ (daridorexant) in China following regulatory approval for adult insomnia treatment. The therapy belongs to the dual orexin receptor antagonist class and supports improved sleep onset and maintenance outcomes. This expansion strengthened Simcere’s neuroscience portfolio and enhanced access to novel insomnia treatments in the Chinese healthcare system.
- In May 2025, Eisai Co., Ltd. received regulatory approval in China for its orexin receptor antagonist DAYVIGO (lemborexant), marking a significant advancement in insomnia treatment options. The product was subsequently launched in the Chinese market to address patients with sleep onset and sleep maintenance disorders. This introduction expanded the availability of next-generation pharmacological therapies targeting the sleep-wake cycle mechanism.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Key companies operating in the China sleep-wake disorder market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- China Sleep-Wake Disorder Market Sales Analysis – Disorder Type | Treatment Type | Diagnosis & Management Approach | Application ($ Million)
- Sleep-Wake Disorder Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Sleep-Wake Disorder Industry Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Sleep-Wake Disorder Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For China Sleep-Wake Disorder Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For China Sleep-Wake Disorder Market: Impact Analysis
- Market Opportunities
- Opportunities For China Sleep-Wake Disorder Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Sleep-Wake Disorder Market Revenue and Share by Manufacturers
- Sleep-Wake Disorder Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- BeiGene Ltd
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Jiangsu Hengrui Pharmaceuticals Co. Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Shanghai Fosun Pharmaceutical Group Co. Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Shanghai Pharmaceuticals Holding Co. Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Sinopharm Group Co. Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership and Collaboration
- BeiGene Ltd
- Key Company Analysis
- China Sleep-Wake Disorder Market Sales Analysis by Disorder Type ($ Million)
- Insomnia
- Hypersomnia
- Sleep Apnea
- Circadian Rhythm Sleep-Wake Disorders
- Parasomnias
- Dyssomnias
- Others
- China Sleep-Wake Disorder Market Sales Analysis by Treatment Type ($ Million)
- Pharmacological Therapy
- Behavioral Therapy
- Light Therapy
- Device-Based Therapy
- Others
- China Sleep-Wake Disorder Market Sales Analysis by Diagnosis & Management Approach ($ Million)
- Polysomnography & Sleep Studies
- Actigraphy-Based Monitoring
- Clinical Evaluation & Screening Tools
- Remote / Digital Sleep Monitoring Solutions
- China Sleep-Wake Disorder Market Sales Analysis by Application ($ Million)
- Hospitals
- Home Care Settings
- Others
- Company Profiles
- Apeloa Pharmaceutical Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BeiGene Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Beijing Continent Pharmaceutical Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Chengdu Kanghong Pharmaceutical Group Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- China Meheco Group Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- China National Pharmaceutical Group Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Chongqing Zhifei Biological Products Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eisai Co Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hisun Pharmaceutical Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Idorsia Pharmaceuticals Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Jiangsu Hengrui Pharmaceuticals Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Jiangsu Nhwa Pharmaceutical Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Livzon Pharmaceutical Group Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shandong Luoxin Pharmaceutical Group Stock Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shanghai Fosun Pharmaceutical Group Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shanghai Pharmaceuticals Holding Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shenzhen Salubris Pharmaceuticals Co Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sichuan Kelun Pharmaceutical Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Simcere Pharmaceutical Group Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sinopharm Group Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Tianjin Chase Sun Pharmaceutical Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Yunnan Baiyao Group Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zhejiang Huahai Pharmaceutical Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Apeloa Pharmaceutical Co. Ltd.
1. China Sleep-Wake Disorder Market Research and Analysis by Disorder Type, 2025-2035 ($ Million)
2. China Insomnia Disorder Market Research and Analysis, 2025-2035 ($ Million)
3. China Hypersomnia Disorder Market Research and Analysis, 2025-2035 ($ Million)
4. China Sleep Apnea Disorder Market Research and Analysis, 2025-2035 ($ Million)
5. China Circadian Rhythm Sleep-Wake Disorder Market Research and Analysis, 2025-2035 ($ Million)
6. China Parasomnias Disorder Market Research and Analysis, 2025-2035 ($ Million)
7. China Dyssomnias Disorder Market Research and Analysis, 2025-2035 ($ Million)
8. China Other Sleep-Wake Disorder Market Research and Analysis, 2025-2035 ($ Million)
9. China Sleep-Wake Disorder Market Research and Analysis by Treatment Type, 2025-2035 ($ Million)
10. China Sleep-Wake Disorder by Pharmacological Therapy Market Research and Analysis, 2025-2035 ($ Million)
11. China Sleep-Wake Disorder by Behavioral Therapy Market Research and Analysis, 2025-2035 ($ Million)
12. China Sleep-Wake Disorder by Light Therapy Market Research and Analysis, 2025-2035 ($ Million)
13. China Sleep-Wake Disorder by Device-Based Therapy Market Research and Analysis, 2025-2035 ($ Million)
14. China Sleep-Wake Disorder by Other Treatment Type Market Research and Analysis, 2025-2035 ($ Million)
15. China Sleep-Wake Disorder Market Research and Analysis by Diagnosis & Management Approach, 2025-2035 ($ Million)
16. China Polysomnography & Sleep Studies Market Research and Analysis, 2025-2035 ($ Million)
17. China Actigraphy-Based Monitoring Market Research and Analysis, 2025-2035 ($ Million)
18. China Clinical Evaluation & Screening Tools Market Research and Analysis, 2025-2035 ($ Million)
19. China Remote / Digital Sleep Monitoring Solutions Market Research and Analysis, 2025-2035 ($ Million)
20. China Sleep-Wake Disorder Market Research and Analysis by Application, 2025-2035 ($ Million)
21. China Sleep-Wake Disorder for Hospitals Market Research and Analysis, 2025-2035 ($ Million)
22. China Sleep-Wake Disorder for Home Care Settings Market Research and Analysis, 2025-2035 ($ Million)
23. China Sleep-Wake Disorder for Other Application Market Research and Analysis, 2025-2035 ($ Million)
1. China Sleep-Wake Disorder Market Share by Disorder Type, 2025 Vs 2035 (%)
2. China Insomnia Disorder Market Share, 2025 Vs 2035 (%)
3. China Hypersomnia Disorder Market Share, 2025 Vs 2035 (%)
4. China Sleep Apnea Disorder Market Share, 2025 Vs 2035 (%)
5. China Circadian Rhythm Sleep-Wake Disorder Market Share, 2025 Vs 2035 (%)
6. China Parasomnias Disorder Market Share, 2025 Vs 2035 (%)
7. China Dyssomnias Disorder Market Share, 2025 Vs 2035 (%)
8. China Other Sleep-Wake Disorder Market Share, 2025 Vs 2035 (%)
9. China Sleep-Wake Disorder Market Share by Treatment Type, 2025 Vs 2035 (%)
10. China Sleep-Wake Disorder by Pharmacological Therapy Market Share, 2025 Vs 2035 (%)
11. China Sleep-Wake Disorder by Behavioral Therapy Market Share, 2025 Vs 2035 (%)
12. China Sleep-Wake Disorder by Light Therapy Market Share, 2025 Vs 2035 (%)
13. China Sleep-Wake Disorder by Device-Based Therapy Market Share, 2025 Vs 2035 (%)
14. China Sleep-Wake Disorder by Other Treatment Type Market Share, 2025 Vs 2035 (%)
15. China Sleep-Wake Disorder Market Share by Diagnosis & Management Approach, 2025 Vs 2035 (%)
16. China Polysomnography & Sleep Studies Market Share, 2025 Vs 2035 (%)
17. China Actigraphy-Based Monitoring Market Share, 2025 Vs 2035 (%)
18. China Clinical Evaluation & Screening Tools Market Share, 2025 Vs 2035 (%)
19. China Remote / Digital Sleep Monitoring Solutions Market Share, 2025 Vs 2035 (%)
20. China Sleep-Wake Disorder Market Share by Application, 2025 Vs 2035 (%)
21. China Sleep-Wake Disorder for Hospitals Market Share, 2025 Vs 2035 (%)
22. China Sleep-Wake Disorder for Home Care Settings Market Share, 2025 Vs 2035 (%)
23. China Sleep-Wake Disorder for Other Application Market Share, 2025 Vs 2035 (%)
- Printable version
- No restriction to number of users within the company
